Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011

OBJECTIVES This study analyzed the prevalence of attention deficit hyperactivity disorder (ADHD) medication use among children and adolescents in Korea between January 1, 2007 and December 31, 2011. METHODS Using the Korea National Health Insurance claims database, we identified patients between one...

Full description

Bibliographic Details
Main Authors: Inmyung Song, Ju-Young Shin
Format: Article
Language:English
Published: Korean Society of Epidemiology 2016-10-01
Series:Epidemiology and Health
Subjects:
Online Access:http://www.e-epih.org/upload/pdf/epih-38-e2016045.pdf
_version_ 1818676489977069568
author Inmyung Song
Ju-Young Shin
author_facet Inmyung Song
Ju-Young Shin
author_sort Inmyung Song
collection DOAJ
description OBJECTIVES This study analyzed the prevalence of attention deficit hyperactivity disorder (ADHD) medication use among children and adolescents in Korea between January 1, 2007 and December 31, 2011. METHODS Using the Korea National Health Insurance claims database, we identified patients between one and 17 years of age who had at least one medical claim for the diagnosis of ADHD (International Classification of Diseases, 10th revision: F90.0). The annual prevalence of ADHD diagnoses was calculated, using national census data from Statistics Korea on the population aged between one and 17 years as the denominator. The prevalence was age-standardized using the 2010 population as the standard population. The number of patients who were treated with methylphenidate and/or atomoxetine and the prevalence of total patients with ADHD that were treated with either drug were also calculated for each year. All analyses were stratified according to gender and age group (1-5 years, 6-12 years, and 13-17 years). RESULTS The number of patients diagnosed with ADHD increased from 72,704 persons (0.71%) in 2007 to 85,468 persons (0.93%) in 2011. The annual age-standardized prevalence of ADHD diagnoses increased from 0.67% in 2007 to 0.94% in 2011. The prevalence of methylphenidate use among children and adolescents with ADHD decreased from 73.91% in 2007 to 70.33% in 2011, whereas that of atomoxetine use increased from 5.77% in 2009 to 13.09% in 2011. CONCLUSIONS While methylphenidate remains the most commonly prescribed ADHD drug, the use of atomoxetine has increased.
first_indexed 2024-12-17T08:44:18Z
format Article
id doaj.art-9a73be4307c2484d8e66e58c35cc1dcd
institution Directory Open Access Journal
issn 2092-7193
language English
last_indexed 2024-12-17T08:44:18Z
publishDate 2016-10-01
publisher Korean Society of Epidemiology
record_format Article
series Epidemiology and Health
spelling doaj.art-9a73be4307c2484d8e66e58c35cc1dcd2022-12-21T21:56:15ZengKorean Society of EpidemiologyEpidemiology and Health2092-71932016-10-013810.4178/epih.e2016045870Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011Inmyung Song0Ju-Young Shin1 Division of Risk Assessment and International Cooperation, Centers for Disease Control and Prevention, Cheongju, Korea School of Pharmacy, Sungkyunkwan University, Suwon, KoreaOBJECTIVES This study analyzed the prevalence of attention deficit hyperactivity disorder (ADHD) medication use among children and adolescents in Korea between January 1, 2007 and December 31, 2011. METHODS Using the Korea National Health Insurance claims database, we identified patients between one and 17 years of age who had at least one medical claim for the diagnosis of ADHD (International Classification of Diseases, 10th revision: F90.0). The annual prevalence of ADHD diagnoses was calculated, using national census data from Statistics Korea on the population aged between one and 17 years as the denominator. The prevalence was age-standardized using the 2010 population as the standard population. The number of patients who were treated with methylphenidate and/or atomoxetine and the prevalence of total patients with ADHD that were treated with either drug were also calculated for each year. All analyses were stratified according to gender and age group (1-5 years, 6-12 years, and 13-17 years). RESULTS The number of patients diagnosed with ADHD increased from 72,704 persons (0.71%) in 2007 to 85,468 persons (0.93%) in 2011. The annual age-standardized prevalence of ADHD diagnoses increased from 0.67% in 2007 to 0.94% in 2011. The prevalence of methylphenidate use among children and adolescents with ADHD decreased from 73.91% in 2007 to 70.33% in 2011, whereas that of atomoxetine use increased from 5.77% in 2009 to 13.09% in 2011. CONCLUSIONS While methylphenidate remains the most commonly prescribed ADHD drug, the use of atomoxetine has increased.http://www.e-epih.org/upload/pdf/epih-38-e2016045.pdfAttention deficit hyperactivity disorderMethylphenidateAtomoxetine hydrochlorideAttentionPrescriptions
spellingShingle Inmyung Song
Ju-Young Shin
Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011
Epidemiology and Health
Attention deficit hyperactivity disorder
Methylphenidate
Atomoxetine hydrochloride
Attention
Prescriptions
title Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011
title_full Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011
title_fullStr Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011
title_full_unstemmed Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011
title_short Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011
title_sort prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in korea 2007 2011
topic Attention deficit hyperactivity disorder
Methylphenidate
Atomoxetine hydrochloride
Attention
Prescriptions
url http://www.e-epih.org/upload/pdf/epih-38-e2016045.pdf
work_keys_str_mv AT inmyungsong prescribingpatternsforattentiondeficithyperactivitydisordermedicationsamongchildrenandadolescentsinkorea20072011
AT juyoungshin prescribingpatternsforattentiondeficithyperactivitydisordermedicationsamongchildrenandadolescentsinkorea20072011